| SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids J Jansen, KC Reimer, JS Nagai, FS Varghese, GJ Overheul, M de Beer, ... Cell Stem Cell 29 (2), 217-231. e8, 2022 | 171 | 2022 |
| COVID moonshot: open science discovery of SARS-CoV-2 main protease inhibitors by combining crowdsourcing, high-throughput experiments, computational simulations, and machine … H Achdout, A Aimon, E Bar-David, GM Morris BioRxiv, 2020 | 53 | 2020 |
| Photochemical in-flow synthesis of 2, 4-methanopyrrolidines: pyrrolidine analogues with improved water solubility and reduced lipophilicity VV Levterov, O Michurin, PO Borysko, S Zozulya, IV Sadkova, ... The Journal of Organic Chemistry 83 (23), 14350-14361, 2018 | 48 | 2018 |
| Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors COVID Moonshot Consortium, H Achdout, A Aimon, DS Alonzi, R Arbon, ... BioRxiv, 2020.10. 29.339317, 2020 | 36 | 2020 |
| Delivering Structural Information on the Polar Face of Membrane‐Active Peptides: 19F‐NMR Labels with a Cationic Side Chain OM Michurin, S Afonin, M Berditsch, CG Daniliuc, AS Ulrich, IV Komarov, ... Angewandte Chemie 128 (47), 14815-14819, 2016 | 35 | 2016 |
| Direct nucleophilic difluoromethylation of enolizable ketones with CHF2TMS/HMPA OM Michurin, DS Radchenko, IV Komarov Tetrahedron 72 (10), 1351-1356, 2016 | 26 | 2016 |
| Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors ML Boby, D Fearon, M Ferla, M Filep, L Koekemoer, MC Robinson, ... Science 382 (6671), eabo7201, 2023 | 23 | 2023 |
| An easy synthesis of α-trifluoromethyl-amines from aldehydes or ketones using the Ruppert-Prakash reagent DS Radchenko, OM Michurin, AV Chernykh, O Lukin, PK Mykhailiuk Tetrahedron Letters 54 (14), 1897-1898, 2013 | 21 | 2013 |
| Confining the χ space of basic natural amino acids: Cyclobutane-derived χ1, χ2-constrained analogues of arginine, lysine and ornithine DS Radchenko, OM Michurin, OO Grygorenko, K Scheinpflug, M Dathe, ... Tetrahedron 69 (2), 505-511, 2013 | 16 | 2013 |
| Conformationally Constrained Mono‐Fluorinated Arginine as a Cationic Label for Solid‐State 19F NMR Analysis of Membrane‐Bound Peptides OM Michurin, K Tolmachova, S Afonin, O Babii, SL Grage, AS Ulrich, ... European Journal of Organic Chemistry 2018 (27-28), 3826-3833, 2018 | 9 | 2018 |
| Synthesis of 3‐Azabicyclo [3.2. 0] heptane‐Derived Building Blocks via [3+ 2] Cycloaddition AA Homon, OV Hryshchuk, S Trofymchuk, O Michurin, Y Kuchkovska, ... European Journal of Organic Chemistry 2018 (40), 5596-5604, 2018 | 8 | 2018 |
| 4‐(Di‐/Trifluoromethyl)‐2‐heterabicyclo [2.1. 1] hexanes: Advanced Fluorinated Phenyl Isosteres and Proline analogues AA Homon, OV Hryshchuk, OV Mykhailenko, BV Vashchenko, ... European Journal of Organic Chemistry 2021 (47), 6580-6590, 2021 | 7 | 2021 |
| Diastereopure Synthesis of Novel Cyclohexane-Ring-Based Constrained Lanthionine and α-Methyllanthionine through an SN2 Reaction with a β-Bromoalanine as a Key Step J Gracia-Vitoria, Á Carretero, I Osante, C Cativiela Synlett 31 (04), 383-387, 2020 | | 2020 |
| Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses (preprint) K Kistler, T Bedford, A Undale, K Arora, NM Arora, BPD Purkayastha, ... | | 2020 |
| A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies (preprint) X Chen, M Gentili, N Hacohen, A Regev, H Barr, A Ben-Shmuel, J Bennett, ... | | 2020 |
| PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2 (preprint) S Mazumder, R Rastogi, A Undale, K Arora, NM Arora, BPD Purkayastha, ... | | 2020 |
| Open Science Discovery of Oral Non-Covalent SARS-CoV-2 Main Protease Inhibitor Therapeutics (preprint) H Achdout, A Aimon, E Bar-David, H Barr, A Ben-Shmuel, J Bennett, ... | | 2020 |
| Conformationally-rigid pyrrolidines with improved water solubility V Levterov, P Mykhailiuk, O Michurin, D Granat, A Tolmachev | | |
| Proline analogues: advanced building blocks for drug design V Bilenko, V Dolovanyuk, O Grygorenko, Y Ivon, I Komarov, I Kondratov, ... medicinal chemistry 1, 10, 0 | | |
